FDA
-
-
-
-
-
-
-
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
-
-
-
-
-
-
-
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Issues Statement on Tariffs
-
-
-
-
-
-
-
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Announces Partial Paydown of Revolving Credit Facility
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV and BIVIGAM
-
327,949 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

